| Focus: | To improve the quality of life of people with arthritis, decrease the personal, societal and economic burden of the disease and promote the growth of the Canadian economy through arthritis R&D. |
| Funding: | $55,209,000 for entire funding period |
| Strength: | 208 researchers and 965 highly qualified personnel |
| Partnership Power: | 228 industry, public service and academic partners |
| Scientific Directors: | Dr. Claire Bombardier and Dr. Monique Gignac |
| Web site: |